PE20000333A1 - Metodo para tratar desordenes compulsivos obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso y autismo - Google Patents
Metodo para tratar desordenes compulsivos obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso y autismoInfo
- Publication number
- PE20000333A1 PE20000333A1 PE1999000169A PE00016999A PE20000333A1 PE 20000333 A1 PE20000333 A1 PE 20000333A1 PE 1999000169 A PE1999000169 A PE 1999000169A PE 00016999 A PE00016999 A PE 00016999A PE 20000333 A1 PE20000333 A1 PE 20000333A1
- Authority
- PE
- Peru
- Prior art keywords
- disorders
- chloro
- hydroxy
- methyl
- autism
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE AL USO DE 0,01 mg/Kg A 500 mg/Kg DE UN ANTAGONISTA D1 Y/O D5 SIENDO DE PREFERENCIA (-)-TRANS-6,7,7a,8,9,13b-HEXAHIDRO-3-CLORO-2-HIDROXI-N-METIL-5-H-BENZO[d]NAFTO{2,1-b}AZEPINA.HCl; (R)-(+)-8-CLORO-2,3,4,5-TETRAHIDRO-3-METIL-5-FENIL-1H-3-BENZAZEPIN-7-OL MALEATO; (S)-1-(1-(2-CLOROFENIL)CICLOPROPIL)-7-HIDROXI-6-METOXI-2-METIL-1,2,3,4-TETRAHIDROISOQUINOLINA; 1-(2-BROMO-4,5-DIMETOXIBENCIL)-7-HIDROXI-6-METOXI-2-METIL-1,2,3,4-TETRAHIDROISOQUINOLINA; 8-CLORO-3-[6-(DIMETILAMINO)HEXIL]-2,3,4,5-TETRAHIDRO-5-FENIL-1H-3-BENZAZEPIN-7-OL; 8-CLORO-3-[4-(DIMETILAMINO)BUTIL]-2,3,4,5-TETRAHIDRO-5-FENIL-1H-3-BENZAZEPIN-7-OL; S(+)-8-CLORO-5-(5-BROMO-2,3-DIHIDROBENZOFURAN-7-IL)-7-HIDROXI-3-METIL-2,3,4,5-TETRAHIDRO-1H-3-BENZAPINA, PARA EL TRATAMIENTO DE DESORDENES OBSESIVO COMPULSIVO, DESORDENES SOMATOFORMES, DESORDENES DISOCIATIVOS, DESORDENES DE CONTROL DE IMPULSO (JUEGO POR DINERO, COMPRA COMPULSIVA, COMPULSION SEXUAL PATOLOGICOS), AUTISMO, DESORDENES AL COMER (ANOREXIA NERVIOSA, BULIMIA, GLOTONERIA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3320598A | 1998-03-02 | 1998-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000333A1 true PE20000333A1 (es) | 2000-05-13 |
Family
ID=21869083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000169A PE20000333A1 (es) | 1998-03-02 | 1999-03-01 | Metodo para tratar desordenes compulsivos obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso y autismo |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1058551A1 (es) |
| JP (1) | JP2002505291A (es) |
| KR (1) | KR20010041477A (es) |
| CN (1) | CN1291893A (es) |
| AR (1) | AR018297A1 (es) |
| AU (1) | AU2778099A (es) |
| BR (1) | BR9908392A (es) |
| CA (1) | CA2322201A1 (es) |
| CO (1) | CO4910136A1 (es) |
| HU (1) | HUP0101057A3 (es) |
| IL (1) | IL137715A0 (es) |
| NO (1) | NO20004363L (es) |
| PE (1) | PE20000333A1 (es) |
| SK (1) | SK12962000A3 (es) |
| WO (1) | WO1999044615A1 (es) |
| ZA (1) | ZA991638B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410527B1 (en) * | 1998-03-02 | 2002-06-25 | Schering Corporation | Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism |
| RU2374245C1 (ru) | 2008-08-22 | 2009-11-27 | Андрей Александрович Иващенко | Лиганд с широким спектром одновременной рецепторной активности, фармацевтическая композиция, способ ее получения и лекарственное средство |
| EP3919060A1 (en) * | 2012-07-12 | 2021-12-08 | Emalex Biosciences, Inc. | Ecopipam for treatment of tourettes syndrome |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605897A (en) * | 1991-04-23 | 1997-02-25 | Eli Lilly And Company | 2-methyl-thieno-benzodiazepine |
-
1999
- 1999-03-01 HU HU0101057A patent/HUP0101057A3/hu unknown
- 1999-03-01 PE PE1999000169A patent/PE20000333A1/es not_active Application Discontinuation
- 1999-03-01 CA CA002322201A patent/CA2322201A1/en not_active Abandoned
- 1999-03-01 AR ARP990100860A patent/AR018297A1/es unknown
- 1999-03-01 JP JP2000534217A patent/JP2002505291A/ja not_active Withdrawn
- 1999-03-01 CO CO99012525A patent/CO4910136A1/es unknown
- 1999-03-01 BR BR9908392-2A patent/BR9908392A/pt not_active IP Right Cessation
- 1999-03-01 SK SK1296-2000A patent/SK12962000A3/sk unknown
- 1999-03-01 AU AU27780/99A patent/AU2778099A/en not_active Abandoned
- 1999-03-01 CN CN99803496A patent/CN1291893A/zh active Pending
- 1999-03-01 EP EP99908318A patent/EP1058551A1/en not_active Withdrawn
- 1999-03-01 WO PCT/US1999/003721 patent/WO1999044615A1/en not_active Application Discontinuation
- 1999-03-01 IL IL13771599A patent/IL137715A0/xx unknown
- 1999-03-01 KR KR1020007009634A patent/KR20010041477A/ko not_active Application Discontinuation
- 1999-03-01 ZA ZA9901638A patent/ZA991638B/xx unknown
-
2000
- 2000-09-01 NO NO20004363A patent/NO20004363L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0101057A2 (hu) | 2001-08-28 |
| JP2002505291A (ja) | 2002-02-19 |
| AU2778099A (en) | 1999-09-20 |
| NO20004363L (no) | 2000-10-31 |
| BR9908392A (pt) | 2000-10-31 |
| IL137715A0 (en) | 2001-10-31 |
| EP1058551A1 (en) | 2000-12-13 |
| WO1999044615A1 (en) | 1999-09-10 |
| KR20010041477A (ko) | 2001-05-25 |
| SK12962000A3 (sk) | 2001-08-06 |
| ZA991638B (en) | 1999-09-01 |
| NO20004363D0 (no) | 2000-09-01 |
| AR018297A1 (es) | 2001-11-14 |
| CO4910136A1 (es) | 2000-04-24 |
| CA2322201A1 (en) | 1999-09-10 |
| HUP0101057A3 (en) | 2001-09-28 |
| CN1291893A (zh) | 2001-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000006085A3 (en) | Compounds and methods | |
| HK1069767A1 (en) | Methods for inhibiting ocular processes | |
| ZA200206575B (en) | Novel combination of non-sedative anti-histamines containing substaces which influence the action of leukotriene, for treating rhinitis/conjunctivitis. | |
| MA26914A1 (fr) | Derives bicycliques substitues pour le traitement d'une croissance cellulaire anormale | |
| WO1999047131A3 (en) | Combination of a gaba-a alpha 5 inverse agonist and an acetylcholinesterase inhibitor | |
| IL146082A0 (en) | Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains | |
| GT199900013A (es) | Tratamiento de la disfuncion sexual femenina. | |
| MXPA01002240A (es) | Tratamiento selectvio de receptores de somatostatina endoteliales. | |
| AU5457500A (en) | Water-in-oil emulsified make-up composition | |
| WO1999024051A3 (de) | Verwendung von vasopressin-antagonisten zur behandlung von störungen oder erkrankungen des innenohres | |
| AU4531001A (en) | Compounds with 5-HT<sub>1A</sub> activity useful for treating disorders of the outer retina | |
| DE60203797D1 (de) | Benzo[d]azepin-derivative als 5-ht6-rezeptor-antagonisten | |
| EP0835869A3 (en) | New serotonin 5-HT1F agonists | |
| MA28583B1 (fr) | Dérivés de pyrimidine pour le traitement d'une croissance cellulaire anormale | |
| MXPA03010019A (es) | COMPOSICIoN PARA TRATAR EL ESTREnIMIENTO INDUCIDO POR FaRMACOS CON 15-CETO-PROSTAGLANDINAS. | |
| BR9915129A (pt) | Antagonistas do receptor de crf e processos relacionados aos mesmos | |
| DE502004011551D1 (de) | 1,3,4-substituierte pyrazole als 5-ht rezeptor-antagonisten zur behandlung von psychosen und neurologischen störungen | |
| WO2002024695A3 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
| WO2003001968A3 (en) | Compositions and methods for inhibiting platelet activation and thrombosis | |
| PE20000333A1 (es) | Metodo para tratar desordenes compulsivos obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso y autismo | |
| IL162475A0 (en) | Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists | |
| WO2002039118A8 (en) | Screening methods for bone morphogenetic mimetics | |
| WO2002062323A3 (en) | Use of mglur5 antagonists for the treatment of pruritic conditions | |
| WO2006025920A3 (en) | Modulators of central nervous system neurotransmitters | |
| WO2001007431A3 (en) | Benzothiophene derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |